Alliance Pharma PLC received a notification of major holdings from Van Lanschot Kempen Investment Management NV. The reason for the notification was an acquisition or disposal of voting rights, with the threshold being crossed on 31st May 2024 and the issuer being notified on 4th June 2024. The total positions of Van Lanschot Kempen Investment Management NV show a 8.911100% of voting rights attached to shares, with a total of 48,155,694 voting rights held in the issuer.
The details of the resulting situation on the date on which the threshold was crossed or reached indicate that 8.911100% of voting rights are attached to shares, with 4,134,354 direct voting rights and 44,021,340 indirect voting rights. Additionally, there are no voting rights through financial instruments.
The person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the issuer. There is no information in relation to the proxy voting.
This notification provides an insight into the major shareholding of Alliance Pharma PLC by Van Lanschot Kempen Investment Management NV, detailing the voting rights and the resulting situation.